Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 10: 2950, 2019.
Article in English | MEDLINE | ID: mdl-31921196

ABSTRACT

The skin and intestine are active organs of the immune system that are constantly exposed to the outside environment. They support diverse microbiota, both commensal and pathogenic, which encompass bacteria, viruses, fungi, and parasites. The skin and intestine must maintain homeostasis with the diversity of commensal organisms present on epithelial surfaces. Here we review the current literature pertaining to epithelial barrier formation, microbial composition, and the complex regulatory mechanisms governing the interaction between the innate immune system and microbiota in the skin and intestine. We also compare and contrast the skin and intestine-two different organ systems responsible creating a protective barrier against the external environment, each of which has unique mechanisms for interaction with commensal populations and host repair.


Subject(s)
Gastrointestinal Microbiome/immunology , Immunity, Innate , Intestines , Skin , Humans , Intestines/immunology , Intestines/microbiology , Organ Specificity/immunology , Skin/immunology , Skin/microbiology
2.
Sci Rep ; 6: 26100, 2016 05 17.
Article in English | MEDLINE | ID: mdl-27185466

ABSTRACT

The development of live viral vaccines relies on empirically derived phenotypic criteria, especially small plaque sizes, to indicate attenuation. However, while some candidate vaccines successfully translated into licensed applications, others have failed safety trials, placing vaccine development on a hit-or-miss trajectory. We examined the determinants of small plaque phenotype in two dengue virus (DENV) vaccine candidates, DENV-3 PGMK30FRhL3, which produced acute febrile illness in vaccine recipients, and DENV-2 PDK53, which has a good clinical safety profile. The reasons behind the failure of PGMK30FRhL3 during phase 1 clinical trial, despite meeting the empirically derived criteria of attenuation, have never been systematically investigated. Using in vitro, in vivo and functional genomics approaches, we examined infections by the vaccine and wild-type DENVs, in order to ascertain the different determinants of plaque size. We show that PGMK30FRhL3 produces small plaques on BHK-21 cells due to its slow in vitro growth rate. In contrast, PDK53 replicates rapidly, but is unable to evade antiviral responses that constrain its spread hence also giving rise to small plaques. Therefore, at least two different molecular mechanisms govern the plaque phenotype; determining which mechanism operates to constrain plaque size may be more informative on the safety of live-attenuated vaccines.


Subject(s)
Dengue Virus/physiology , Viral Plaque Assay , Animals , Cell Line , Cricetinae , Dengue Vaccines/adverse effects , Dengue Virus/genetics , Dengue Virus/growth & development , Dengue Virus/immunology , Host-Pathogen Interactions , Humans , Vaccines, Attenuated/adverse effects , Virulence
3.
PLoS Pathog ; 6(2): e1000776, 2010 Feb 19.
Article in English | MEDLINE | ID: mdl-20174553

ABSTRACT

Cryptococcus neoformans is a prevalent human fungal pathogen that must survive within various tissues in order to establish a human infection. We have identified the C. neoformans Rim101 transcription factor, a highly conserved pH-response regulator in many fungal species. The rim101 multiply sign in circle mutant strain displays growth defects similar to other fungal species in the presence of alkaline pH, increased salt concentrations, and iron limitation. However, the rim101 multiply sign in circle strain is also characterized by a striking defect in capsule, an important virulence-associated phenotype. This capsular defect is likely due to alterations in polysaccharide attachment to the cell surface, not in polysaccharide biosynthesis. In contrast to many other C. neoformans capsule-defective strains, the rim101 multiply sign in circle mutant is hypervirulent in animal models of cryptococcosis. Whereas Rim101 activation in other fungal species occurs through the conserved Rim pathway, we demonstrate that C. neoformans Rim101 is also activated by the cAMP/PKA pathway. We report here that C. neoformans uses PKA and the Rim pathway to regulate the localization, activation, and processing of the Rim101 transcription factor. We also demonstrate specific host-relevant activating conditions for Rim101 cleavage, showing that C. neoformans has co-opted conserved signaling pathways to respond to the specific niche within the infected host. These results establish a novel mechanism for Rim101 activation and the integration of two conserved signaling cascades in response to host environmental conditions.


Subject(s)
Cryptococcus neoformans/physiology , Cryptococcus neoformans/pathogenicity , Cyclic AMP-Dependent Protein Kinases/metabolism , Fungal Proteins/metabolism , Host-Parasite Interactions/physiology , Signal Transduction/physiology , Animals , Blotting, Southern , Blotting, Western , Cyclic AMP-Dependent Protein Kinases/genetics , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Genes, Fungal , Immunoprecipitation , Mice , Microscopy, Fluorescence , Oligonucleotide Array Sequence Analysis , Transcription Factors/metabolism , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...